News

  • Women As One Award winner leads the charge in VESALIUS-CV results

    By Women As One When the VESALIUS-CV trial was conceived in 2018, it began a multi-year effort to answer a critical question in preventive cardiology. Could evolocumab, marketed as Repatha, a human monoclonal antibody that inhibits PCSK9, reduce major cardiovascular events in patients at high risk but without a prior myocardial infarction or stroke? The [...]

  • New NHS gene database could help identify cancer risk and personalise treatment

    A new NHS gene database of 120 cancer-linked genes will help patients in England and their families assess their cancer risk, the health service says. People will be able to have their genetic information compared with the register, which NHS England has described as a world first. Those identified as having an inherited risk will [...]

  • “Impact without infrastructure”: Why elite sport is still failing female physiology

    As a new global study exposes systemic gaps in how elite sport manages menstrual health, those behind it explain how current systems are failing women and why it’s time for a fundamental redesign of high-performance care.  While menstrual health is almost universally recognised as a critical factor in women’s performance, few professional sports organisations have [...]

  • Femtech World Awards to celebrate breakthrough fertility innovations

    Fertility innovation is to set to take centre stage at Femtech World's third annual awards event. The Femtech World Awards will celebrate some of the best examples of leadership, innovation and impact in key areas that affect women's health and wellbeing. The Fertility Innovation of the Year award celebrates a pioneering product, service or initiative [...]

  • HRT linked to greater weight loss on tirzepatide

    Postmenopausal women on hormone replacement therapy lost 35 per cent more weight while taking tirzepatide, a new study suggests. The research reviewed data from 120 participants with overweight or obesity who received tirzepatide, marketed in the UK at Mounjaro, for weight management for 12 or more months. Those using the drug alongside hormone replacement therapy [...]

  • Nearly a third of UK women consider quitting job due to menopause

    Almost a third of women are considering leaving their jobs due to menopause symptoms, with 7 per cent already having quit, new research shows. A survey of 2,000 UK working women aged 40-65 found just under half have changed how they work to cope, including reducing hours, cutting responsibilities, or turning down promotions and training. [...]

  • CryoFuture secures investment for growth

    CryoFuture, a fertility specimen storage and transport company, has secured investment from a Chicago-based family office-backed firm. The San Mateo-based company runs seven fertility-dedicated storage sites across the US and provides cryogenic transport services (moving biological materials at ultra-low temperatures) for IVF clinics and patients. CryoFuture was founded by senior embryologist Sean Pae and healthcare [...]

  • Pinky Promise raises US$1m pre-seed funding

    Pinky Promise, a Mumbai-based digital clinic for women's health, has raised US$1m in pre-seed funding. Pinky Promise runs a mobile app offering AI-assisted consultations with gynaecologists, with prices from Rs 99 (about US$1.15). It covers over 320 symptoms and conditions including menstrual health, urinary tract infections, fertility, pregnancy and PCOS (polycystic ovary syndrome, a hormonal [...]

  • Obesity and estrogen use may increase blood clot risk in menopause

    Obesity and oestrogen-based medicines together raise blood clot risk in premenopausal women, research finds. The study explains how these factors combine to amplify thrombotic risk (dangerous blood clots) and offers insight to improve care for people already at higher risk, including those with cancer. Researchers found that thrombosis risk rises sharply in premenopausal women with [...]

  • IVF device developers secure £3.5m investment

    Researchers developing an IVF device to improve embryo number and quality have secured £3.5m in investment. Dr Virginia Pensabene and professor Helen Picton have created a microfluidic device that aims to increase the number and quality of embryos within an IVF cycle. As of 2025, only 25 to 30 per cent of women aged 35 [...]